Biomind Labs Inc (BMND)

NEO
1.28
-0.02(-1.54%)
  • Volume:
    556
  • Bid/Ask:
    1.20/1.28
  • Day's Range:
    1.28 - 1.30
  • Type:Equity
  • Market:Canada
  • ISIN:CA0907021012
  • CUSIP:90702101

BMND Overview

Prev. Close
1.3
Day's Range
1.28-1.3
Revenue
-
Open
1.3
52 wk Range
1.07-1.8
EPS
-0.01
Volume
556
Market Cap
-
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,511
P/E Ratio
-
Beta
-1.66
1-Year Change
-
Shares Outstanding
-
Next Earnings Date
-
What is your sentiment on Biomind Labs Inc?
or
Vote to see community's results!

Biomind Labs Inc Company Profile

Employees
6
Market
Canada

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND02 – N, N-dimethytryptamine that is in Phase II clinical trials for use in the treatment of depression; and BMND01 – Ayahuasca, a product candidate in pre-clinical trials for use in the treatment of smoking addiction. Its product candidates in evaluation stage include BMND03 – Psilocybin for treating chronic pain; BMND04 – Mescaline for treating eating disorders and neurodegenerative diseases; and BMND05 – 5-MeO-DMT, an anti-inflammatory product. The company is based in Toronto, Canada.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.